Kobyliak, N., Delev, D., al., e. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats,
, .
Kobyliak, N., Delev, D., al., e. .
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats.
: , .
Kobyliak, N., Delev, D., al., e. ()
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats,
:
Kobyliak, N.,
Delev, D., &
al., e.
().
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. Biomedicine and Pharmacotherapy; Biomedicine and Pharmacotherapy.